Clinical TrialApr 14, 2026, 07:47 AM
AVITA Medical Cohealyx Reduces Graft Time by ~20 Days in Study
AI Summary
AVITA Medical announced positive interim results from its Cohealyx-I multi-center study, demonstrating a significant reduction in mean time to skin grafting for patients with full-thickness wounds. The mean time to graft was reduced to 13.6 days, nearly 20 days faster than the 33.2-day real-world benchmark, showing statistical superiority. These results, along with high investigator satisfaction, suggest Cohealyx has the potential to improve patient outcomes and drive broader adoption in clinical practice.
Key Highlights
- Mean time to graft reduced to 13.6 days vs. 33.2 days benchmark (~20 day reduction).
- Median time to graft was 11 days, with grafting achieved as early as 5 days.
- 72% of patients were grafted within 14 days.
- 90% investigator satisfaction reported at the time of grafting.
- Results demonstrated statistical superiority (p<0.001) versus a literature-derived benchmark.